According to Mirati Therapeutics's latest financial reports the company's current revenue (TTM ) is €36.37 Million. In 2022 the company made a revenue of €11.59 Million a decrease over the revenue in the year 2021 that were of €63.65 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.